Quality of clinicians’ conversations with patients and families before and after implementation of the Serious Illness Care Program in a hospital setting: a retrospective chart review study

Michael G. DeGroote School of Medicine (Ma, Riehm), Faculty of Health Sciences, McMaster University, Hamilton, Ont.; Harvard Medical School (Bernacki, Paladino); Department of Psychosocial Oncology and Palliative Care (Bernacki), Dana-Farber Cancer Institute; Ariadne Labs (Bernacki, Paladino), Brigham and Women’s Hospital and Harvard T.H. Chan School of Public Health; Department of Medicine (Bernacki, Paladino), Brigham and Women’s Hospital, Boston, Mass.; Division of General Internal and Hospitalist Medicine (You), Trillium Health Partners, Mississauga, Ont.; Departments of Medicine and of Health Research Methods, Evidence, and Impact (You), McMaster University, Hamilton, Ont.

Michael G. DeGroote School of Medicine (Ma, Riehm), Faculty of Health Sciences, McMaster University, Hamilton, Ont.; Harvard Medical School (Bernacki, Paladino); Department of Psychosocial Oncology and Palliative Care (Bernacki), Dana-Farber Cancer Institute; Ariadne Labs (Bernacki, Paladino), Brigham and Women’s Hospital and Harvard T.H. Chan School of Public Health; Department of Medicine (Bernacki, Paladino), Brigham and Women’s Hospital, Boston, Mass.; Division of General Internal and Hospitalist Medicine (You), Trillium Health Partners, Mississauga, Ont.; Departments of Medicine and of Health Research Methods, Evidence, and Impact (You), McMaster University, Hamilton, Ont.

Michael G. DeGroote School of Medicine (Ma, Riehm), Faculty of Health Sciences, McMaster University, Hamilton, Ont.; Harvard Medical School (Bernacki, Paladino); Department of Psychosocial Oncology and Palliative Care (Bernacki), Dana-Farber Cancer Institute; Ariadne Labs (Bernacki, Paladino), Brigham and Women’s Hospital and Harvard T.H. Chan School of Public Health; Department of Medicine (Bernacki, Paladino), Brigham and Women’s Hospital, Boston, Mass.; Division of General Internal and Hospitalist Medicine (You), Trillium Health Partners, Mississauga, Ont.; Departments of Medicine and of Health Research Methods, Evidence, and Impact (You), McMaster University, Hamilton, Ont.

Michael G. DeGroote School of Medicine (Ma, Riehm), Faculty of Health Sciences, McMaster University, Hamilton, Ont.; Harvard Medical School (Bernacki, Paladino); Department of Psychosocial Oncology and Palliative Care (Bernacki), Dana-Farber Cancer Institute; Ariadne Labs (Bernacki, Paladino), Brigham and Women’s Hospital and Harvard T.H. Chan School of Public Health; Department of Medicine (Bernacki, Paladino), Brigham and Women’s Hospital, Boston, Mass.; Division of General Internal and Hospitalist Medicine (You), Trillium Health Partners, Mississauga, Ont.; Departments of Medicine and of Health Research Methods, Evidence, and Impact (You), McMaster University, Hamilton, Ont.

Michael G. DeGroote School of Medicine (Ma, Riehm), Faculty of Health Sciences, McMaster University, Hamilton, Ont.; Harvard Medical School (Bernacki, Paladino); Department of Psychosocial Oncology and Palliative Care (Bernacki), Dana-Farber Cancer Institute; Ariadne Labs (Bernacki, Paladino), Brigham and Women’s Hospital and Harvard T.H. Chan School of Public Health; Department of Medicine (Bernacki, Paladino), Brigham and Women’s Hospital, Boston, Mass.; Division of General Internal and Hospitalist Medicine (You), Trillium Health Partners, Mississauga, Ont.; Departments of Medicine and of Health Research Methods, Evidence, and Impact (You), McMaster University, Hamilton, Ont.